EURAX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Eurax, and when can generic versions of Eurax launch?
Eurax is a drug marketed by Journey and is included in two NDAs.
The generic ingredient in EURAX is crotamiton. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the crotamiton profile page.
Summary for EURAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 94 |
Patent Applications: | 3,860 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for EURAX |
DailyMed Link: | EURAX at DailyMed |
US Patents and Regulatory Information for EURAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journey | EURAX | crotamiton | CREAM;TOPICAL | 006927-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Journey | EURAX | crotamiton | LOTION;TOPICAL | 009112-003 | Approved Prior to Jan 1, 1982 | AT | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |